Published, Version of Record (VoR)CC BY V4.0, Open
Abstract
Genetics & Heredity Life Sciences & Biomedicine Science & Technology
Homologous recombination (HR) plays an important role in maintaining genomic integrity. It is responsible for repair of the most harmful DNA lesions, DNA double-strand breaks and inter-strand DNA cross-links. HR function is also essential for proper segregation of homologous chromosomes in meiosis, maintenance of telomeres, and resolving stalled replication forks. Defects in HR often lead to genetic diseases and cancer. Rad52 is one of the key HR proteins, which is evolutionarily conserved from yeast to humans. In yeast, Rad52 is important for most HR events; Rad52 mutations disrupt repair of DNA double-strand breaks and targeted DNA integration. Surprisingly, in mammals, Rad52 knockouts showed no significant DNA repair or recombination phenotype. However, recent work demonstrated that mutations in human RAD52 are synthetically lethal with mutations in several other HR proteins including BRCA1 and BRCA2. These new findings indicate an important backup role for Rad52, which complements the main HR mechanism in mammals. In this review, we focus on the Rad52 activities and functions in HR and the possibility of using human RAD52 as therapeutic target in BRCA1 and BRCA2-deficient familial breast cancer and ovarian cancer.
Reappearance from Obscurity: Mammalian Rad52 in Homologous Recombination
Creators
Kritika Hanamshet - Drexel University
Olga M. Mazina - Drexel University
Alexander V. Mazin - Drexel University
Publication Details
Genes, v 7(9)
Publisher
Mdpi
Number of pages
18
Grant note
J.N.Tata Trust Endowment scholarship (India)
Basser Innovation Award
R01GM115927 / NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)
CA188347; GM115927-01 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
R01CA188347 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
Drexel Clinical Translational Research Institute (CTRI) award
Resource Type
Journal article
Language
English
Academic Unit
Biochemistry and Molecular Biology
Web of Science ID
WOS:000385535300009
Scopus ID
2-s2.0-84989326340
Other Identifier
991019168016604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: